首页> Leukemia and lymphoma> Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

导出原文传递

翻译打印收藏纠错

第一作者： Kiesewetter, Barbara

作者： Kiesewetter, Barbara ^[1] ; Raderer, Markus

作者单位： Med Univ Vienna, Dept Internal Med 1, Div Oncol, Vienna, Austria ^[1]

发布时间 2015-10-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia and lymphoma

2015年56卷2期

548-549页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Leukemia and lymphoma

2015年56卷2期

548-549页

检索历史清除

Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

Leukemia and lymphoma

相似文献

同项目论文

Leukemia and lymphoma

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

Leukemia and lymphoma

相似文献

同项目论文

Leukemia and lymphoma

相关期刊

检索历史清除